• U.S.-based FingerMotion is a communications technology services company focused on the enormous Chinese consumer base and its adoption of mobile devices
• FingerMotion has established its operations on a stable tripod of services including SMS, MMS, and big data technologies
• The company recently reported growing revenues derived primarily from its SMS and MMS products
• On Oct. 25 the company introduced two new brands for value-added services that will help underwrite protection plans for mobile devices during the coming year
• FingerMotion expects its big data platform Sapientus to eventually outstrip SMS and MMS revenues as it becomes a significant tool for establishing consumer risk predictive services for China’s 1.4 billion people

Communications technology company FingerMotion (OTCQX: FNGR) is establishing itself as a powerhouse in consumer access within China’s enormous mobile technology use population base. Building on its recently reported 25 percent YOY quarterly revenue growth from short and multimedia messaging (SMS and MMS) services (https://ibn.fm/zSohm), the company has added two brands that will pair with a large American insurance company to help with underwriting mobile device protection programs (https://ibn.fm/tDEub). FingerMotion’s trademarked big data platform, Sapientus, has gained attention because of its unparalleled access to China’s consumers, handling over half a million transactions daily for its mobile payment and recharge services while providing the foundation for an insurtech industry capable of analyzing insurance and credit risks in a market where credit scoring infrastructure is not as developed as in the United States. Global insurer Pacific Life reached an agreement with FingerMotion earlier this year that effectively positions FingerMotion as the data provider for Pacific Life’s Re-insurance division (https://ibn.fm/sD9On). SMS functions such as mobile texting, MMS functions such as photo and video sharing, and big data analysis for Sapientus’ algorithm clients provide the three tripod legs sustaining FingerMotion’s business model and its sphere of innovation. The newest brands are trademarked as Ji Shi Fu and Baowo under FingerMotion’s subsidiary Shanghai JiuGe Information Technology Co., Ltd. The brands are expected to provide value-add services by covering mobile consumer maintenance needs such as broken phone screens, accidental damage repairs and compensation, and older device trade-in’s. The company states the services will come online early next year and could generate new revenue channels from more than 10 of China’s provinces, beginning with beta testing this month in Shanghai, Guangdong, Anjui, Zhejiang, and Henan provinces. “This latest development demonstrates the flexibility of our business model to explore ways to monetize our vast active user base,” CEO Martin Shen stated in the company’s news release. China has become a sought-after market as companies have established footholds for the businesses internationally, primarily because of China’s world-leading population, which is expected to top 1.4 billion this year. The country is developing one of the world’s fastest growing economies and is increasingly accessible to outside interests. FingerMotion expects its existing unique opportunity to collect and store big data for the Chinese economy and convert it into something actionable for end users without having to expend great sums in marketing and consumer retention will continue to grant it an attractive investment profile. For more information, visit the company’s website at www.FingerMotion.com. NOTE TO INVESTORS: The latest news and updates relating to FNGR are available in the company’s newsroom at https://ibn.fm/FNGR

• Lexaria recently announced the commencement of EPIL-A21-1, an animal study to evaluate whether DehydraTECH-CBD has similar or superior efficacy in reducing or inhibiting seizure activity compared to FDA-approved seizure drug, Epidiolex
• The study will also compare DehydraTECH-CBD to generic CBD
• EPIL-A21-1 has entered early-stage preparatory work, with results expected in Q3 2022
• Lexaria received new patent awards in Mexico and Japan, strengthening its IP portfolio to 23 granted patents

Lexaria Bioscience (NASDAQ: LEXX), the drug delivery platform innovator behind the disruptive, patented DehydraTECH(TM) technology, recently announced it had commenced an important new animal study, EPIL-A21-1 (https://ibn.fm/LG7O6). EPIL-A21-1, which will be conducted by a talented team that includes respirology and neurology experts, will explore whether DehydraTECH-processed cannabidiol (“CBD”) evidences similar or superior efficacy in reducing or inhibiting seizure activity compared to Epidiolex, which is now sold by Jazz Pharmaceuticals (“Jazz”) subsequent to the 2021 US$7.2 billion takeover of GW Pharmaceuticals plc by Jazz. The study will also compare DehydraTECH-CBD to generic CBD. With laboratory studies, research reports, and anecdotal evidence suggesting that CBD could potentially control seizures, and results from clinical trials involving Epidiolex – now the first FDA-approved CBD-based drug for the treatment of seizures associated with two rare and severe forms of pediatric epilepsy, Dravet syndrome and Lennox-Gastaut syndrome – indicating the advantageous effects of CBD in treating treatment-resistant seizure disorders, this non-psychoactive component of marijuana represents hope for patients who have been resistant to conventional anti-seizure drugs (https://ibn.fm/6NQ5E). Through previous human and animal studies, Lexaria has evidenced that DehydraTECH improves the speed of onset is more effective at delivering CBD into the bloodstream, and increases brain absorption of CBD. Having already shown success with CBD, Lexaria believes the DehydraTECH technology could potentially improve therapeutic efficacy for a range of disease conditions affecting the central nervous system, including epilepsy, hence the EPIL-A21-1 study. The study is being conducted by a leading US-based independent laboratory using advanced DehydraTECH 2.0 formulations and has entered early-stage preparatory work. Results are expected by Q3 2022. Elsewhere, Lexaria, which as of September of 2021 had 21 issued patents and more than 50 pending patent applications globally (https://ibn.fm/i2Ku2), recently announced it had received its first patent award for DehydraTECH in Mexico and another in Japan. The patent award in Mexico safeguards the proprietary technology for use with cannabinoids and nicotine, while the patent in Japan is for the use of DehydraTECH with non-psychoactive cannabinoids, vitamins, nicotine, or non-steroidal anti-inflammatory (“NSAID”) substances. These are two of the five patents that have been awarded to Lexaria in 2021.  The pair also strengthen the company’s IP portfolio with a collection that now includes 23 granted patents covering multiple countries. Lexaria is a global leader in enhancing the speed and efficiency of orally-delivered fat-soluble APIs and drugs through its proprietary drug delivery technology, DehydraTECH. The technology pairs APIs with fatty acids such as long-chain fatty acid before applying the resulting combination to carrier particles like gum Arabic or sorbitol. The product then undergoes a dehydration synthesis procedure before being rendered for use in the desired final form factor. Through this proprietary and revolutionary technology, Lexaria makes it possible to deliver bioactive substances via oral ingestion without the need for unhealthy, deleterious practices of inhalation dosing, as is the case with nicotine, and without the need for co-administration with harmful sugars or sweeteners commonly used to mask bitter tastes. For more information, visit the company’s website at www.LexariaBioscience.com. NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://ibn.fm/LEXX

• Cannabis Strategic Ventures’ 2020 revenue jumped 517% year-over-year to $14.6 million
• 2020 revenues from cannabis sales were $14.1 million, up 975% compared to fiscal 2019
• The company’s gross profit spiked 483% year-over-year, reaching $2.78 million in 2020, while gross margins held steady at about 20 percent
• Cannabis Strategic Ventures will launch its first Los Angeles dispensary in Q4 2021
• The company will open an indoor cultivation facility with capacity to produce up to 15,000 pounds of premium cannabis flower annually

Cannabis Strategic Ventures (OTC: NUGS) is an emerging leader in the U.S. cannabis marketplace as a publicly traded cannabis cultivator. The company is based in Los Angeles, with a 6-acre cannabis farm in Northern California called NUGS Farm North. The company’s vision is to acquire and scale assets in the legal cannabis market while achieving efficiencies through economies of scale and vertical integration. Cannabis Strategic Ventures recently expanded its portfolio by completing the transfer process for cultivation, retail, distribution and manufacturing licenses issued by the City of Los Angeles and the State of California, and it is now working toward taking operational control of each license. The company also recently announced the upcoming grand opening of its cannabis dispensary, MDRN Tree. Following that launch, Cannabis Strategic Ventures intends to deploy another of its new licenses to establish an indoor cultivation facility with capacity to produce two to three pounds of premium exotic cannabis flower per light per harvest. The facility will have up to 1,200 grow lights and is anticipated to yield 5.75 harvests per year, bringing it to a total production capacity of over 15,000 pounds of cannabis flower annually. Brand Portfolio The company owns multiple brands under the Cannabis Strategic Ventures umbrella. The firm’s NUGS brand provides operational and financial strategic partnerships and a range of essential services to emerging and existing cannabis consumer brands. The NUGS Farm North brand operates as a six-and-a-half-acre cannabis cultivation property located in northern California. The company believes that the key to success in its business is consistent quality and reliable supply to fit growing consumer demand. Cannabis Strategic Ventures addressed these consumer needs by building NUGS Farm North. At NUGS Farm North, the company’s process is customized, and its product is consistent. Located in the heart of an agricultural mecca for globally distributed produce, NUGS Farm North finds power in its product, not in its size. Decades of agricultural experience and a dedication to consistency ensure quality cannabis. MDRN Tree is Cannabis Strategic Ventures’ customer-facing dispensary brand. MDRN Tree will open its first Los Angeles location sometime in the fall of 2021. MDRN Tree will be the company’s factory retail store – a direct interface with the end-market community – where Cannabis Strategic Ventures plans on showcasing the cannabis flower produced at its NUGS Farm North cultivation site. This farm-to-sale model offers the potential to drive simultaneous gains in quality control and profitability. Market Outlook The demand for legal marijuana is expected to surge due to ongoing changes in U.S. state government policies toward cannabis. In addition, the number of indications for which medical marijuana is prescribed continues to increase steadily. These factors are expected to rapidly boost legal sales of cannabis products, opening new revenue channels for producers and retailers. Furthermore, an anticipated federal legalization of medical marijuana in the U.S. will only present more high growth opportunities for this market. According to a report from Grand View Research, the global legal marijuana market was valued at $9.1 billion in 2020. Market size is forecast to grow at a compound annual growth rate of 26.7 percent from 2021 to 2028. That CAGR would put the market value at roughly $30 billion as soon as 2025. According to the report, “One of the major factors fueling market growth is the expanding demand for legal marijuana owing to the growing number of legal cannabis countries. (Due) to recent legalizations in different countries, the use of medical marijuana for various ailments is gaining momentum worldwide. Patients suffering from chronic illnesses such as Parkinson’s, cancer, Alzheimer’s, and many neurological disorders are administered medical marijuana. The demand for cannabis oil is increasing rapidly, especially among countries with legalized medical marijuana.” Management Team Simon Yu is CEO, President, CFO and Secretary of Cannabis Strategic Ventures. He is also a co-founder, former COO and board member of Clubhouse Media Group Inc., a publicly traded social media company. Mr. Yu holds an MBA from the University of Southern California. For more information, visit the company’s website at www.CannabisStrategic.com. NOTE TO INVESTORS: The latest news and updates relating to NUGS are available in the company’s newsroom at http://ibn.fm/NUGS

• Since the 19^th century, average global temperatures have increased by over 2 degrees Fahrenheit
• Since 1971, climate change has slowed down the growth in agricultural productivity by about a fifth as a result of human activity
• It is estimated that the transportation, energy and food sectors alone can directly eliminate over 90% of net greenhouse gas (“GHG”) emissions worldwide in just 15 years
• FuelPositive, through its modular and scalable carbon-free ammonia system, is offering a solution that cuts across these three sectors, ultimately reducing GHG emissions
• With its technology, the company is defining the ongoing disruption within these sectors and laying down the foundation of what the future could look like

A recent study from Cornell University revealed that since 1971, climate change, as a result of human activity, has slowed down the growth in agricultural productivity by about a fifth (https://ibn.fm/YuCV3). This study further noted that the sensitivity of agricultural productivity increases as temperatures rise, meaning that each additional fraction of a degree is more detrimental to food production than the last. The planet today is experiencing overall temperatures that are higher than ever and continues to warm as time progresses. Since the 19^th century, average temperatures have increased by over 2 degrees Fahrenheit, with the trend persisting and perhaps accelerating (https://ibn.fm/HwV3a). Agriculture is not the only affected sector. The energy sector has also fallen victim to climate change. As of 2019 in the United States, most of the country’s electricity was generated by natural gas, followed by coal and nuclear energy. Renewable sources such as hydropower, wind, geothermal, biomass, and solar power generate only 17% of the country’s electricity (https://ibn.fm/B0WEZ). With the mounting pressure to ditch coal, coupled with climate change and its impact on hydropower, the government is being forced to look for more sustainable alternative energy production and storage solutions. FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF) is a company that is committed to clean energy solutions. It understands the impact of global warming and climate change. It is, as such, at the forefront of offering a sustainable solution that cuts across the energy, transportation and food sectors. Through its carbon-free ammonia, available for use in a variety of applications, FuelPositive is confident that it can help to significantly reduce CO2 emissions and offer long-term storage of excess electricity for energy grids. Combined, the application to the transportation, energy and food sectors alone could directly eliminate over 90% of net greenhouse gas (“GHG”) emissions worldwide in just 15 years. Market experts have even pointed out that market forces can be tapped to push the bulk of global GHG emissions mitigation, mainly since the technologies required are either already commercially available and competitive today or can be deployed to the market by 2025 (https://ibn.fm/ILy0e). FuelPositive’s carbon-free ammonia is a solution that make a significant difference in the near future — as early as 2022. It is a solid and sustainable solution that can help mitigate the global GHG emissions, and it cuts across these three key sectors. For agriculture, the company’s carbon-free ammonia can eliminate fertilizer-related carbon emissions, reducing the overall carbon footprint and the accompanying GHG emissions in this sector (https://ibn.fm/pu2Pn). As for transportation, FuelPositive’s solution can provide an affordable, convenient and sustainable supply of hydrogen for fuel cells. Alternatively, research has proven that carbon-free ammonia can be used on its own as a fuel. Planes, trains, trucks, ships, and even small vehicles can be easily converted to run on ammonia, just as easily as they can be converted from gasoline and diesel to run on propane (https://ibn.fm/Z88Sk). As for energy generation, FuelPositive’s carbon-free ammonia is the perfect catalyst that will enable the shift to a hydrogen economy. As well, it offers easy long-term storage of excess electricity for energy grids while also making it easy to provide electricity to northern or remote communities (https://ibn.fm/Hzn4t). This is mainly attributed to several key factors associated with ammonia. For one, FuelPositive’s carbon-free ammonia requires 30% less energy than conventional ammonia production, with zero carbon emissions. Secondly, it stores 65% more hydrogen than highly compressed hydrogen while keeping costs low from start to finish (https://ibn.fm/d3Opd). The carbon-free ammonia is also easy to produce and store on site, making it a suitable energy source for individuals and communities living in remote areas. With the ongoing climate change problem, there is a growing need to remedy the situation. The three sectors — energy, transportation and the food sectors — have been marked as key contributors to this change and key areas that need to be addressed if the issue is to be fixed. FuelPositive understands this urgency, hence its focus on these sectors and offering a solid solution with its carbon-free ammonia. Through its modular and scalable technology, the company is defining the ongoing disruption within these sectors and laying down the foundation of what the future will look like. Its technology and solutions have been tried and tested, and with it, net greenhouse gas emissions will reduce in the coming years. For more information, visit the company’s website at www.FuelPositive.com. NOTE TO INVESTORS: The latest news and updates relating to NHHHF are available in the company’s newsroom at https://ibn.fm/NHHHF

• Laredo Oil Inc. is an oil and gas E&P company engaged in acquiring, developing and operating both conventional oil and gas properties and select mature oil fields that are suitable for the use of the company’s proprietary EOR methods
• Regardless of the property, the company focuses on value, growth upside and free cash flow
• Laredo Oil has acquired leases on 23,739 mineral acres in Montana
• Laredo Oil has identified 10 initial drilling locations, with the intention to drill the first development well in calendar 2021

Laredo Oil (OTC: LRDC) is a publicly traded oil and gas exploration and production (E&P) company engaging in the acquisition and development of both undervalued quality conventional oil and gas properties and select mature oil fields that are suitable for the company’s proprietary Enhanced Oil Recovery (“EOR”) methods. Laredo Oil is headquartered in Austin, Texas. Conventional Acreage Laredo Oil’s primary focus is on acquiring, developing, and operating undervalued conventional oil and gas properties. The company leased 23,739 mineral acres in the Western Williston Basin of Montana, at favorable prices during the most recent down cycle and continues to take leases in the area. Before year end, it expects to drill the first development well at one of the first of 10 potential locations it has identified. If that well yields the anticipated results, the company plans to begin drilling additional wells there as soon as practical thereafter. The company believes the leased acreage has the potential to yield at least five years of development opportunities. The company intends to pursue aggressively the acquisition of quality assets that major, mid-major, and large independent oil and gas companies continue to divest themselves of at a discount in response to ESG (Environmental, Social and Governmental) & sustainability initiatives and other pressures imposed upon them by their activist boards of directors. The company will focus on value, growth potential and free cash flow while complying with common sense ESG policies, often having a lower environmental impact than its competitors through its EOR methods. EOR In addition to pursuing conventional acreage and properties, Laredo Oil plans to acquire additional select mature oil fields where it believes that it can profitably use its proprietary Underground Gravity Drainage(TM) (“UGD”) model to recover stranded oil reserves (reserves previously considered to be economically incapable of recovery). The UGD method is applicable to mature oil fields that have very specific geological and reservoir characteristics. Laredo Oil has done extensive research and field level application over the last 10 years and has identified specific oil fields within the United States that it believes are qualified for the UGD recovery method. The company believes the costs of implementing the UGD method are significantly lower than those of other commonly used EOR methods. Laredo Oil believes that it can materially increase the field oil production rate from prior periods and, in some cases, recover amounts of oil equal to or greater than amounts previously recovered from the mature fields selected. Market Outlook The company expects U.S. oil prices to climb in the near term as energy demand intensifies with the economy continuing to recover from the COVID-19 slowdown. Also causing upward price pressure is global supply chain dysfunction that slows or prevents shipments, including energy components, from reaching destinations. Domestic oil production is also constrained by years of reduced investment in fossil fuel producers due to green energy mandates. Accordingly, the company believes that the short-term outlook for oil is favorable. Many industries have yet to reach their pre-COVID production levels, which the company believes points to a continuing near-term upward trend in energy demand. Management Team Mark See has been the Chief Executive Officer and Chairman of the Board of Directors of the company since October 16, 2009. He has over 30 years’ experience in heavy civil, natural resources and the E&P industries. He was the founder and founding CEO of Rock Well Petroleum, a private oil & gas company until December 2008 and worked from then until October 2009 forming Laredo Oil. He was employed with Albian Sands as the Manager for the Alberta Oil Sands Projects at Fort McMurray, Alberta, Canada, a joint venture between Shell Canada and Chevron. Mr. See was also President of Oil Recovery Enhancement LLC in Bozeman, Montana, a private oil company. He was selected as one of the top 25 Engineers in North America by the Engineering News Record for his innovations in the petroleum industry. He is a graduate of the Mackay School of Mines at the University of Nevada at Reno, with a degree in Mining Engineering. He is a member of the Society of Mining Engineers and the Society of Petroleum Engineers. Bradley Sparks currently serves as the Chief Financial Officer and Treasurer of Laredo Oil and has been a director of the company since March 1, 2011. Before joining Laredo Oil in October 2009, he was the Chief Executive Officer, President and a Director of Visualant Inc. Prior to joining Visualant, he was the Chief Financial Officer of WatchGuard Technologies Inc. from 2005-2006. Before joining WatchGuard, he was the founder and managing director of Sunburst Growth Ventures LLC, a private investment firm specializing in emerging-growth companies. Previously, he founded Pointer Communications and served as Chief Financial Officer for several telecommunications and internet companies, including eSpire Communications Inc., Digex Inc., Omnipoint Corporation, and WAM!NET. He also served as Vice President and Treasurer of MCI Communications from 1988-1993 and as Vice President and Controller from 1993-1995. Before his tenure at MCI, Mr. Sparks held various financial management positions at Ryder System Inc. He currently serves on the Board of Directors of Comrise. Mr. Sparks graduated from the United States Military Academy at West Point in 1969 and is a former Army Captain in the Signal Corps. He has a Master of Science in Management from the Sloan School of Management at the Massachusetts Institute of Technology and is a licensed CPA in Florida. Donald Beckham has served as a director of the company since March 1, 2011. Since July 2015, he has been a partner with Copestone Energy Partners LLC. In 1993, he founded Beckham Resources Inc. (“BRI”), which, for over 30 years, has been a licensed, bonded and insured operator in good standing with the Railroad Commission of Texas. Through BRI, Mr. Beckham has drilled and operated fields for his own account. His expertise is in the acquisition, exploitation, exploration and production enhancement of mature oil and gas fields through which he has been able to enhance production by compressor optimization, pump design, work-over programs, stimulation techniques and identifying new pay zones. Prior to BRI, Mr. Beckham was the chief operations manager for Houston Oil Fields Corporation (“HOFCO”), where he began his career. There, he was responsible for drilling, production and field operations and managed approximately 100 people, including engineers, geologists, land men, pumpers, and other contract personnel, as well as state and federal environmental and regulatory functions. He managed an annual capital budget of approximately $30 million and operated approximately 100 wells. HOFCO drilled about 20 wells per annum and performed approximately 30 recompletions and work over operations each year. HOFCO owned interests in about 10 key fields principally in Texas, and company-managed production was approximately 1,000 bpd of crude oil and 10 mm cfd of natural gas. Mr. Beckham is a petroleum engineer and 1984 graduate of Mississippi State University. Michael Price, an independent director of Laredo Oil, has over 40 years of senior financial and petroleum experience in the global oil and gas industry. He has been a principal in Octagon Energy Advisors, a Houston-based energy investment advisory firm, from 2002 to the present. The firm advises financial institutions and institutional investors participating in energy investments. From 2008 through his retirement in 2021, he was a Managing Director at ING Capital, which provides debt financing to domestic exploration and production companies. From 1998 through 2002, Mr. Price was the Chief Financial Officer of Forman Petroleum Corporation. Before that, Mr. Price was Managing Director at Chase Manhattan Bank for 15 years and was in charge of technical support for Chase’s worldwide energy merchant banking activities. In his early career, he worked as a consulting principal on domestic petroleum engineering and landowner matters and gained extensive international experience working with major oil companies in a variety of operating positions. He holds a BS and MS from Illinois Institute of Technology, an MBA from the University of Chicago, a M.Sc. from the London School of Economics, and an MS in Petroleum Engineering from Tulane University. For more information, visit the company’s website at www.Laredo-Oil.com. NOTE TO INVESTORS: The latest news and updates relating to LRDC are available in the company’s newsroom at https://ibn.fm/LRDC

• The COP26 climate change summit is taking place Oct. 31-Nov. 12 in Glasgow at the Scottish Event Campus (“SEC”) after being delayed last year due to the COVID-19 pandemic
• The overall consensus worldwide is to strive for zero emissions by 2050 – requiring energy solutions that emit no greenhouse gases and are environmentally sustainable
• FuelPositive’s modular and scalable carbon-free ammonia system offers more hydrogen than highly compressed hydrogen and is highly competitive with other methods of replacing fossil fuels
• The green ammonia market is expected to grow at a CAGR of 54.9% over the next decade

After being postponed because of the COVID-19 pandemic last year, the COP26 climate change summit is taking place Oct. 31 – Nov. 12, at the Scottish Event Campus (“SEC”) in Glasgow. Discussing the importance of the climate change summit, the chair of the Energy Transitions Commission, Adair Turner, highlighted the role of companies and governments in reducing emissions. In a CNBC Europe interview, Turner, who served as chair of UK’s Financial Services Authority between 2008 and 2013, stated that “almost everybody has now agreed that we’ve got to get the global economy to about zero emissions by 2050.” He also talked about how renewable technologies, batteries and electrolyzing hydrogen are far more inexpensive than originally thought a decade ago (https://ibn.fm/GYKoa). Even though green hydrogen is the overall goal, the industry still faces many difficulties. Producing hydrogen is energy-intensive, and the end product is highly volatile. At normal temperatures, hydrogen escapes and leaks into the structure of metals, making them brittle. Storing hydrogen is also complicated because it requires extreme pressure for proper storage. There is virtually no infrastructure available and no safety precautions in place for the distribution and transportation of hydrogen. Toronto-based FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF) offers an alternative to hydrogen distribution issues through its proprietary on-site production of carbon-free ammonia (“NH3”) technology. FuelPositive’s NH3 system is more energy-efficient than conventional forms of NH3 but without carbon emissions. The system also yields 65% more hydrogen than highly compressed hydrogen products, because the ammonia molecule is so stable there is no “boiling off,” no extreme compression required, and no cracking of brittle metals. FuelPositive recently closed its subscription agreement with certain U.S. institutional investors with gross proceeds totaling approximately CAD$7 million (USD$5.66 million). This private placement in the U.S. consists of 30,434,784 common shares and warrants to purchase up to the same amount of common shares for CAD$0.23 (USD$0.19) per common share and warrant. The warrants have an exercise price of CAD$0.25 (USD$0.20) per common share until Oct. 28, 2024. The proceeds from the sale of shares will be used to help deploy more of FuelPositive’s carbon-free ammonia systems into high-profile demonstration projects throughout 2022. Funding may also be used for general corporate purposes as well. H.C. Wainwright & Co. acted as the exclusive placement agent for the private placement in the U.S. (https://ibn.fm/P46uh) FuelPositive’s flagship modular and scalable carbon-free ammonia technology was developed by Dr. Ibrahim Dincer and his esteemed team at Ontario Technology University in Toronto. The platform will allow for in-situ production of NH3 sustainably. The process involves using only water, air and sustainable electricity. Through its proprietary technology, FuelPositive is on track to create a viable option for replacing traditional fossil fuels, while also becoming a leading provider on the expanding green ammonia market. The industry is expected to grow at a CAGR of 54.9% over the next decade. The increase can largely be attributed to the global goal of utilizing green ammonia as a fossil fuel replacement over the next 30 years. (https://ibn.fm/ym2Af) For more information, visit the company’s website at www.FuelPositive.com. NOTE TO INVESTORS: The latest news and updates relating to NHHHF are available in the company’s newsroom at https://ibn.fm/NHHHF

• Health diagnostics solutions provider Avricore Health has established neighborhood lab-accurate medical condition testing platform in 15 sites in Ontario through the Shoppers Drug Mart network earlier this year
• Now Avricore has announced an expansion through the Shoppers Drug Mart agreement to serve five cities in British Columbia
• Avricore’s trademarked HealthTab network partners with pharmacies, kiosk developers and analytical instrument makers to provide patients ready access to data for managing their health in real time with the oversight of trained health professionals
• The point-of-care testing market is expected to generate revenues of $50.6 billion by 2025 as consumers seek more direct involvement in managing their wellness and a means of avoiding the costs and wait times associated with doctors’ office visits

After successfully rolling out a point-of-care health diagnostic platform in a group of Ontario pharmacies, technology innovator Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) is expanding to Canada’s west coast where its product can reach a new market and evaluate the needs of a diverse patient population. Avricore’s flagship HealthTab (TM) platform is a solution that conveniently generates lab-accurate results for select medical conditions and communicates them in real time with patients as well as with trained health care professionals. The platform teams up with neighborhood pharmacies, kiosk station builders and analytical instrument makers to provide patients with the ability to give a simple sample of blood and obtain prompt health management results at accessible pharmacy locations, potentially reducing costs and waiting times associated with busy doctors’ offices and clinics. Through cloud-based technology, the HealthTab platform provides data to the patients’ doctors to facilitate any needed follow-up care. HealthTab’s diagnostic menu screens for up to 23 key biomarkers associated with chronic diseases such as diabetes and heart disease, and now also includes testing for bacteria and viruses such as strep and COVID-19. Avricore initially provided HealthTab services to patients at 15 Ontario pharmacies thanks to a pilot agreement with the Shoppers Drug Mart network. The expansion announced Oct. 26 adds five cities in British Columbia — Richmond, Burnaby, Vancouver, Surrey, and Victoria (https://ibn.fm/pMQqo). The outlets represent a small fraction of Shoppers Drug Mart’s 1,800-pharmacy network, and Avricore says it plans to serve 600 locations by the end of 2023. “Patient feedback, along with that of our pharmacists, has been very positive in Ontario with respect to HealthTab and we are evaluating how more patients can benefit from this type of service,” Shoppers Drug Mart Director of Complex Care Frank Hack stated in the news release. “In coming to British Columbia, we are hoping to learn more about patient needs and serve them in the best way possible.” Avricore anticipates eventually placing its product in other pharmacies in the United States, the United Kingdom and the European Union. “The nice thing is all this technology that we use, everything that we’re doing down there (in the United States), is already approved so we are not at a sort of regulatory or approval risk at any level expanding internationally,” Avricore CEO Hector Bremner said during a recent podcast interview (https://ibn.fm/0q2qB). “We’re also really excited about opportunities in the UK and EU, which, I think people just don’t understand how big a market that really is — it’s still bigger than China and it is a place where I think we can do business reliably. Between the U.S., UK and Canada, there’s about 110,000 pharmacies.” The five cities in British Columbia have already received HealthTab devices ready to analyze for known conditions associated with pre-diabetes, or patients already identified as diabetic to help with management of their condition. By the end of the decade, nearly 13.6 million Canadians are expected to be diabetic or prediabetic — many of them undiagnosed by a physician — according to a report last year by national health charity Diabetes Canada (https://ibn.fm/47Fj4). Analysts at Markets and Markets expect point-of-care testing revenue potential to reach $50.6 billion by 2025, with glucose monitoring for diabetes comprising the largest growing sector of the market (https://ibn.fm/VWziB). For more information on Avricore Health, visit the company’s website at http://www.AvricoreHealth.com. NOTE TO INVESTORS: The latest news and updates relating to AVCRF are available in the company’s newsroom at https://ibn.fm/AVCRF

• Special purpose acquisition company Soaring Eagle Acquisition Corp. combined with Ginkgo Bioworks to form publicly listed Ginkgo Bioworks Holdings Inc., in what is the largest-ever biotechnology go-public transaction
• Ginkgo Bioworks is known for its work in the commercial-scale production of a rare cannabinoid, CBG, for use in a multitude of industrial needs
• InMed uses multiple manufacturing approaches to synthetically produce rare cannabinoids, including CBC which is currently sold through its subsidiary BayMedica
• The success of the Ginkgo IPO suggests the marketplace value associated with the production of rare cannabinoids

Special purpose acquisition company (“SPAC”) Soaring Eagle Acquisition Corp. (NASDAQ: SRNGU, SRNG, SRNGW) recently announced a business combination between itself and Ginkgo Bioworks. The resulting entity made its debut renamed as Ginkgo Bioworks Holdings, Inc. and a public listing on the New York Stock Exchange (“NYSE”) under the ticker symbol DNA. A total of 75% of Soaring Eagle’s shareholders participated in the vote, with 97% of them voting in favor of the combination. The combination closed on September 16, 2021, with the public trade on the NYSE commencing the following day. The $1.6 billion in proceeds from the combination represents the largest biotechnology go-public transaction to date (https://ibn.fm/OSP4s). In recent news, Ginkgo Bioworks announced that the company had made a breakthrough improvement on how they produce a key material used in mRNA vaccine manufacturing and the commercial-scale production of the rare cannabinoid CBG. Like Ginkgo Bioworks, biopharmaceutical company InMed Pharmaceuticals Inc. (NASDAQ: INM) and its subsidiary BayMedica are innovators in the field of rare cannabinoids, making them available for consumer access. InMed specializes in developing a proprietary biosynthesis system for the manufacturing of pharmaceutical-grade cannabinoids that are otherwise too rare to be acquired in abundance. Also, through their recent acquisition of BayMedica, InMed now has capabilities in both yeast biosynthesis and chemical synthesis, catering to the large and growing health and wellness consumer markets. The cannabis plant is made up of over 100 unique cannabinoids, many of which are only found in trace amounts. The initial focus of InMed is the therapeutic benefits of a cannabinoid named cannabinol (“CBN”), which may be helpful in numerous diseases that have a high unmet medical need. With CBN being found in such small amounts in the cannabis plant, InMed is developing IntegraSyn to help create the cannabinoid synthetically in the lab. Currently, InMed has two drugs within its pipeline using CBN — INM-755 and INM-088. INM-755 is a topical compound with CBN to be used for the treatment of epidermolysis bullosa, a severe genetic skin disorder. INM-755 has already been evaluated in two phase I clinical trials, and recently commenced a global phase II study. INM-088 is an ocular CBN treatment for glaucoma. When applied directly to the eye, INM-088 has shown significant promise in reducing intraocular pressure and providing neuroprotection of the eye. With so many of these cannabinoids exhibiting the potential to fulfill several unmet medical needs industry-wide, InMed is working on the answer to mass production of rare and otherwise depleted cannabinoid opportunities. Unlike tetrahydrocannabinol (“THC”) and cannabidiol (“CBD”), which are found in excess within the cannabis plant, the goal for InMed and its subsidiary BayMedica is to use various manufacturing approaches to produce the amounts of rare cannabinoids necessary to fulfill the outstanding medical need in the industry. For more information, visit the company’s website at www.InMedPharma.com. NOTE TO INVESTORS: The latest news and updates relating to INM are available in the company’s newsroom at https://ibn.fm/INM

New York’s recreational marijuana market is poised to begin with a bang — and the Cannabis World Congress & Business Exposition (“CWCBExpo”), which is being held at New York City’s Javits Convention Center, Hall 3A between 4-6 November 2021, is the ideal forum for education, business building and networking on this multifaceted industry. As of Sept. 21, 2021, adult New Yorkers are now able to possess up to three ounces of cannabis for recreational use or up to 24 grams of concentrated cannabis, such as oils derived from a cannabis plant (https://ibn.fm/fo1Cr). With the state’s cannabis industry expected to begin licensed sales from around 2023 onwards, industry entrepreneurs have forecast the sector to generate up to $1.1 billion in revenues within its first year of operations (https://ibn.fm/2u9vJ). Cannabis decriminalization is set to lead to plenty of jobs and tax revenue; according to cannabis marketplace platform, Leafly Holdings Inc., up to 20,000 full time jobs are expected to be created within the first 18 months of legal sales, rising to approximately 60,000 positions within five years. Meanwhile, Leafly forecasts that annual sales for the sector will reach $3.5 billion in the five years post legalization, resulting in tax revenues of approximately $450 million for the state of New York. The CWCBExpo, which has long established a reputation as a leading forum for dispensary owners, growers, suppliers, investors, medical professionals, government regulators, legal counsel, and entrepreneurs looking to achieve business success and identify new areas of growth, has positioned itself as the ideal starting point for entrepreneurs and investors seeking to establish a foothold in New York’s promising cannabis sector. Segmented into three daily sessions– covering “Where We Are Today”, “Challenges & Solutions” and “What’s Next?”, respectively, the conference will seek to address a number of pertinent issues surrounding the ongoing changes within the sector. Topics to be covered include: A full list of the presentation topics to be covered over the three-day event can be found at: https://ibn.fm/KrOe8. In addition to the conference’s wide array of expert speakers and industry thought leaders, the summit will also play host to hundreds of exhibitors set to feature some of the industry’s latest innovations, products and services. Attendees will also be able to participate in an industry networking event, “Back-to-Business Celebration,” which will be held immediately post the first day of the CWCBExpo, wherein conference delegates will be able to network and further their interactions with their fellow peers. For more information about the CWCBExpo, visit www.CWCBExpo.com.

Date: November 2 – 4, 2021 Live Streaming Traders, investors, shareholders and businesses are invited to attend the Interactive MoneyShow Virtual Expo on November 2-4, 2021. MoneyShow has been organizing conferences and seminars for over 40 years with a 100,000+ community of investors, financial heads and businesses looking to gain knowledge and guidance about the latest investment tools, financial trends and opportunities from the stalwarts of the financial arena. The event presents a wonderful opportunity for traders and investors to interact with financial leaders and company experts via interactive message boards. The educational videos and articles serve as a source of a huge knowledge base for new traders, shareholders and investors seeking guidance on the management of investments and growth opportunities in the financial trading segment. The Interactive MoneyShow Expo showcases influential speakers who are eminent personas in their niche. Exhibitors can host live presentations and explain their product and service line in the Virtual Exhibit Hall while availing of great discounts and win numerous prizes in different events. This Virtual Exhibit Hall is a tremendous marketing forum where investors from different backgrounds understand your business and you get an opportunity to develop a long-term association with them. Attendees can participate for free to watch the interactive sessions and live presentations by distinguished financial leaders. These dignitaries will discuss who they are adapting their trading and investment plans as per the current market trends. They will also offer their insights and tips into the future course of action on stocks, bonds and ETFs to options, futures, forex, and more. The interactive sessions offer an in-depth analysis of the current trends so that you can make better trading and investment decisions to enjoy better profits. Inflation will be an important agenda of discussion at the expo where attendees can get valuable guidance and key pointers for managing their investments in the current environment. Presentations will also include detailed explanations on how we can use non-dividend stocks and create our dividend-like cash flow by selling call options. The speaker sessions will be followed by real-life examples as to how to implement option-selling to create a dividend-like cash flow with non-dividend bearing stocks. To know more about the event, please visit https://ibn.fm/Q278k